Pathogenic Lysosomal Depletion in Parkinson's DiseaseBenjamin Dehay, Miquel Vila|Journal of Neuroscience|2010Cited by 802
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Andrew Singleton et al.|The Lancet Neurology|2015Cited by 508
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Serge Przedborski, Céline Perier et al.|Journal of Clinical Investigation|2003Cited by 412
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Serge Przedborski, Céline Perier et al.|Journal of Clinical Investigation|2003Cited by 402
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseMiquel Vila, Serge Przedborski|Proceedings of the National Academy of Sciences|2001Cited by 372